Patient-Helpdesk.com

csl behring patient assistance program

by Dr. Hilma Satterfield IV Published 2 years ago Updated 1 year ago
image

Our Commitment

CSL Behring is committed to the patients we serve. This commitment is reflected in our support of programs and activities for patients with rare diseases including bleeding disorders, primary immune deficiencies, hereditary angioedema, CIDP and Alpha 1 proteinase inhibitor deficiencies.

Patient Organization LEAD Grants

CSL Behring offers $10,000 Local Empowerment for Advocacy Development (LEAD) grants to help patient organizations achieve their advocacy objectives.

What are the values of CSL?

At CSL we are Driven by Our Promise and guided by our Values: Patient Focus, Innovation, Integrity, Collaboration and Superior Performance.

What is clinical research?

Find a Clinical Trial. A clinical trial is a research study that is done to find out if medical treatments can improve people’s health. A medical treatment can be a drug, medical device, medical procedure, or a change in a person’s behavior such as diet or exercise. People who take part in clinical trials are volunteers.

How to enroll in CSL Behring?

Fill out the program enrollment form located to your right. If you don't see an enrollment form available please call CSL Behring program directly. After filling out the enrollment form please bring the form to your doctor for proper signatures and procedures. Do not forget a self stamped envelope for them to mail in your application to the program.

What is CSL Behring?

CSL Behring is the world's largest fully integrated plasma collection company. They are also a global leader in the development of plasma protein biotherapeutics, providing treatments for bleeding disorders, immune disorders, pulmonary disorders, and emphysema. CSL Behring operates dozens of plasma collection facilities throughout the United States and Germany. As a worldwide provider of biotherapies, CSL Behring continues to research and develop unique and innovative solutions while keeping the same outlook as their founding corporation had.

image
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 1 2 3 4 5 6 7 8 9